首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Outcome of untreated grade II rejection on solitary pancreas allograft biopsy specimens.
【24h】

Outcome of untreated grade II rejection on solitary pancreas allograft biopsy specimens.

机译:未经治疗的II级排斥反应在单独胰腺异体移植活检标本上的结果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: The most widely used grading scheme for acute pancreas allograft rejection grades biopsy specimens from 0 (normal) to V (severe rejection). Although the more advanced grades correlate strongly with immunologic graft loss, it is unclear how lesser grades impact graft outcome. The authors therefore report the outcomes of untreated grade II (minimal) rejection of solitary pancreas biopsy specimens. METHODS: The authors retrospectively analyzed all solitary pancreas transplants performed at the Mayo Clinic between January 2001 and November 2002. The authors selected all patients who were found with grade II findings on biopsy. Whether patients underwent follow-up biopsies, what the results were, and graft survival at the end of the study period were then determined. RESULTS: A total of 88 pancreas transplants were performed; 20 pancreas transplant recipients (23%) developed grade II (minimal) rejection and were followed for a mean of 22.8+/-8.7 months. Eighteen patients underwent biopsy for protocol purposes and two patients underwent clinically indicated biopsies. Of the patients who underwent biopsy as per protocol, 15 of the patients had a total of 25 follow-up biopsies: 10 were grade 0; 3 were grade I; and 10 were unchanged (grade II). Rejection in one patient progressed to grade III and in another patient to grade IV. The three patients who did not undergo repeat biopsy had a functioning allograft pancreas at the end of the study period. Of the two patients with grade II biopsy specimens obtained for clinical reasons, one had resolution of all inflammation noted on three follow-up biopsies, and the other patient did not undergo follow-up biopsy and died with a functioning graft. CONCLUSIONS: Grade II (minimal) rejection of solitary pancreas allograft rarely progresses to more severe degrees of inflammation. Morphologic findings in this category may not have unfavorable prognoses over a period of 2 years when untreated.
机译:背景:最广泛使用的急性胰腺同种异体排斥反应的分级方案将活检样本从0(正常)分级为V(严重排斥)。尽管较高的等级与免疫移植物的损失密切相关,但尚不清楚较低的等级如何影响移植物的结果。因此,作者报告了未经治疗的孤立胰腺活检标本的II级(最小)排异反应的结果。方法:作者回顾性分析了2001年1月至2002年11月在Mayo诊所进行的所有孤立胰脏移植。作者选择了所有经活检具有II级检查结果的患者。然后确定患者是否接受了随访活检,结果如何以及研究期末的移植物存活率。结果:共进行了88例胰腺移植; 20位胰腺移植受者(23%)发展为II级(最低)排斥反应,平均随访22.8 +/- 8.7个月。出于协议目的,对18例患者进行了活检,对2例患者进行了临床指征的活检。在按照方案进行活检的患者中,有15名患者进行了25次随访活检:10名为0级; 10名为0级。 3个是I级;和10个保持不变(II级)。一名患者的排斥反应进展为III级,另一名患者的排斥反应进展为IV级。在研究期结束时,三名未进行重复活检的患者均具有正常的同种异体胰腺功能。在两名因临床原因而获得的II级活检标本的患者中,一名患者在三次随访活检中发现所有炎症均已消退,另一名患者未接受随访活检并因功能正常而死亡。结论:孤立胰腺同种异体移植的II级(最低)排斥反应很少会发展为更严重的炎症。如果不进行治疗,则该类别的形态学检查结果可能不会在2年内出现不利的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号